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A 63-year-old woman was referred for evaluation of a massin the lower lobe of the right lung. The patient, a non-
smoker, in 1989 underwent a bilateral ovariohysterectomy for
synchronous enometrioid adenocarcinoma of the uterus and
ovary (stage I uterus, stage IA FIGO ovary). The postopera-
tive follow-up (10 years) was uneventful. Recently, due to a
right chest pain, the patient underwent a chest roentgenogram
demonstrating a mass of the right lower lobe. A subsequent
computed tomography of the chest showed a 40  32 mm
pulmonary mass of the right lower lobe (Fig 1) in which was
also present a 40 mm pure ground glass opacity (Fig 2).
Positron emission tomography showed increased fluorode-
oxyglucose uptake in the posterolateral portion of the right
lower lobe corresponding to the pulmonary mass; hilar and
mediastinal activity was normal. Bronchoscopy, lobar bron-
chial washing, and brushing were negative. Tumor markers
(CA-125, NSE, CYFRA, CEA) were negative. A transtho-
racic biopsy of the mass suggested a metastatic endometrioid
adenocarcinoma. The patient underwent a right thoracotomy,
with a biopsy of the consolidation area of the lung corre-
sponding to the pure ground glass opacity. Because an intra-
operative frozen section suggested a primary bronchioloal-
veolar adenocarcinoma, a right lower lobectomy with
systematic mediastinal limphadenectomy was performed. Fi-
nal pathologic evaluation of the specimens revealed a meta-
static endometrioid adenocarcinoma (Fig 3A), immunoreac-
tive for estrogen (Fig 3B) and progesterone receptors and
negative for TTF-1, corresponding to the mass, and a primary
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FIGURE 1. CT scan of the chest showing a pulmonary
mass of the right lower lobe.
FIGURE 2. CT scan of the chest showing a pure ground
glass opacity of the right lower lobe.
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non-mucinous bronchioloalveolar adenocarcinoma (Fig 3C),
positive for TTF-1 (Fig 3D) and negative for estrogen and
progesterone receptors, corresponding to the ground glass
opacity. Hilar and mediastinal lymph nodes were negative.
The patient then was referred to the oncologist for hormonal
therapy (megestrol acetate) and follow-up.
FIGURE 3. Microscopically the mass consisted of well-differentiated neoplastic glands (A) which were immunoreactive for
estrogen receptors (B); the ground glass opacity was composed of columnar neoplastic cells lining the alveolar wall (C) which
were immunoreactive for TTF-1 (D).
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